Stocks
Vanda Pharmaceuticals (VNDA) ROE US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 28.1% | 5.15% | 6.57% | 1.19% | 0.46% | -3.03% | ||
| Changes by years, y/y, % | +19pp | -23pp | +1pp | -5pp | -1pp | -45.0% | |||
Vanda Pharmaceuticals. ROE, %
Vanda Pharmaceuticals. ROE, changes, pp
Vanda Pharmaceuticals (VNDA) ROE US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROE, % | ? | 2.17% | 0.46% | -0.90% | -2.01% | -3.03% | -3.03% | |
| Changes by years, y/y, % | +1pp | -1pp | -4pp | -5pp | -5pp | |||
| Changes by quarters, q/q, % | -1pp | -2pp | -1pp | -1pp | -1pp | |||
